Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92006521 | 9200652 | 1 | I | 20130227 | 20130228 | 20130331 | 20130331 | PER | US-ASTRAZENECA-2013SE13986 | ASTRAZENECA | 61.00 | YR | F | Y | 59.00000 | KG | 20130331 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92006521 | 9200652 | 1 | PS | SYMBICORT | 1 | INHALATION | 360 MCG TWO TIMES A DAY | D | 21929 | BID | |||||||||
| 92006521 | 9200652 | 2 | SS | MOTRIN | 1 | ORAL | D | 0 | CAPSULE | ||||||||||
| 92006521 | 9200652 | 3 | C | MEDICATION FOR CHOLESTEROL | 2 | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92006521 | 9200652 | 1 | Asthma |
| 92006521 | 9200652 | 3 | Blood cholesterol abnormal |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92006521 | 9200652 | Drug dose omission | |
| 92006521 | 9200652 | Drug hypersensitivity | |
| 92006521 | 9200652 | Dyspnoea | |
| 92006521 | 9200652 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92006521 | 9200652 | 1 | 2010 | 0 |